Search of: United States, New Hampshire - List Results

Rank

Status

Study

Active, not recruiting

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial CAN-NCIC-MA27

Conditions:	Breast Cancer; Cancer-Related Problem/Condition
Interventions:	Drug: alendronate sodium; Drug: calcium carbonate; Drug: calcium citrate; Drug: calcium gluconate; Drug: cholecalciferol; Drug: risedronate sodium; Procedure: dual x-ray absorptometry; Procedure: laboratory biomarker analysis

Recruiting

Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: clodronate disodium; Drug: ibandronate sodium; Drug: zoledronic acid

Recruiting

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Conditions:	Cancer-Related Problem/Condition; Pain; Unspecified Adult Solid Tumor, Protocol Specific
Interventions:	Drug: duloxetine hydrochloride; Drug: placebo

Recruiting

Combination Chemotherapy in Treating Women With Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: cyclophosphamide; Drug: doxorubicin hydrochloride; Drug: paclitaxel

Recruiting

Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer

Conditions:	Breast Cancer; Cancer-Related Problem/Condition
Interventions:	Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment

Recruiting

Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer

Condition:	Colorectal Cancer
Interventions:	Drug: bevacizumab; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin

Active, not recruiting

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

Condition:	Breast Cancer
Interventions:	Procedure: laboratory biomarker analysis; Procedure: mammography; Procedure: pharmacological study

Recruiting

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Condition:	Colorectal Cancer
Interventions:	Drug: bevacizumab; Drug: cetuximab; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin

Recruiting

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: letrozole; Drug: placebo

Active, not recruiting

Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: anastrozole; Drug: exemestane; Procedure: adjuvant therapy

Recruiting

Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer

Condition:	Colorectal Cancer
Interventions:	Drug: cetuximab; Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: oxaliplatin

Recruiting

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Condition:	Breast Cancer
Interventions:	Drug: anastrozole; Drug: exemestane; Drug: letrozole; Drug: tamoxifen citrate; Procedure: chemotherapy

Active, not recruiting

Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy

Condition:	Breast Cancer
Interventions:	Drug: anastrozole; Drug: tamoxifen citrate; Procedure: adjuvant therapy; Procedure: radiation therapy

Recruiting

Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Conditions:	Metastatic Cancer; Prostate Cancer
Interventions:	Drug: placebo; Drug: zoledronic acid

Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

Condition:	Lung Cancer
Interventions:	Drug: bevacizumab; Drug: carboplatin; Drug: cisplatin; Drug: docetaxel; Drug: gemcitabine hydrochloride; Drug: paclitaxel; Drug: vinorelbine ditartrate

Recruiting

Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: bevacizumab; Drug: cyclophosphamide; Drug: paclitaxel; Drug: pegylated liposomal doxorubicin hydrochloride; Drug: placebo

Active, not recruiting

Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer

Condition:	Prostate Cancer
Interventions:	Drug: bicalutamide; Drug: goserelin; Drug: mitoxantrone hydrochloride; Drug: prednisone; Procedure: adjuvant therapy; Procedure: radiation therapy

Recruiting

Letrozole After Tamoxifen in Treating Women With Breast Cancer

Condition:	Breast Cancer
Intervention:	Drug: letrozole

Active, not recruiting

Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma

Condition:	Multiple Myeloma and Plasma Cell Neoplasm
Interventions:	Drug: bortezomib; Drug: pegylated liposomal doxorubicin hydrochloride

Recruiting

Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer

Condition:	Breast Cancer
Interventions:	Drug: anastrozole; Drug: fulvestrant